Assessing the balance between excitation and inhibition in chronic pain through the aperiodic component of EEG
eLife · 13.01.2025 · 13
DOI: 10.7554/elife.101727 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 13.01.2025. Verfasst von Cristina Gil Avila und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany. Hauptthemen laut MEDLINE: Chronic Pain, Electroencephalography, Prefrontal Cortex. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Technical University of Munich.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Chronic pain is a prevalent and debilitating condition whose neural mechanisms are incompletely understood. An imbalance of cerebral excitation and inhibition (E/I), particularly in the medial prefrontal cortex (mPFC), is believed to represent a crucial mechanism in the development and maintenance of chronic pain. Thus, identifying a non-invasive, scalable marker of E/I could provide valuable insights into the neural mechanisms of chronic pain and aid in developing clinically useful biomarkers. Recently, the aperiodic component of the electroencephalography (EEG) power spectrum has been proposed to represent a non-invasive proxy for E/I. We, therefore, assessed the aperiodic component in the mPFC of resting-state EEG recordings in 149 people with chronic pain and 115 healthy participants. We found robust evidence against differences in the aperiodic component in the mPFC between people with chronic pain and healthy participants, and no correlation between the aperiodic component and pain intensity. These findings were consistent across different subtypes of chronic pain and were similarly found in a whole-brain analysis. Their robustness was supported by preregistration and multiverse analyses across many different methodological choices. Together, our results suggest that the EEG aperiodic component does not differentiate between people with chronic pain and healthy individuals. These findings and the rigorous methodological approach can guide future studies investigating non-invasive, scalable markers of cerebral dysfunction in people with chronic pain and beyond.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
- TUM-Neuroimaging Center, TUM School of Medicine and Health, TUM, Munich, Germany.
- Center for Interdisciplinary Pain Medicine, TUM School of Medicine and Health, TUM, Munich, Germany.
- Department of Psychosomatic Medicine and Psychotherapy, School of Medicine and Health, TUM, Munich, Germany.
- Institute for Biomagnetism and Biosignalanalysis, University of Münster, Münster, Germany.
ORCID-Profile: Cristina Gil Avila, Elisabeth S May, Joachim Gross, Markus Ploner
Förderung
- Deutsche Forschungsgemeinschaft
- Technical University of Munich
Zitieren
APA
Gil Avila, C., May, E. S., Bott, F. S., Tiemann, L., Hohn, V., Heitmann, H., Zebhauser, P. T., Gross, J., & Ploner, M. (2025). Assessing the balance between excitation and inhibition in chronic pain through the aperiodic component of EEG. eLife, 13. https://doi.org/10.7554/elife.101727
Vancouver
Gil Avila C, May ES, Bott FS, Tiemann L, Hohn V, Heitmann H, et al. Assessing the balance between excitation and inhibition in chronic pain through the aperiodic component of EEG. eLife. 2025;13. doi:10.7554/elife.101727
BibTeX
@article{GilAvila2025,
author = {Gil Avila, Cristina and May, Elisabeth S and Bott, Felix S and Tiemann, Laura and Hohn, Vanessa and Heitmann, Henrik and Zebhauser, Paul Theo and Gross, Joachim and Ploner, Markus},
title = {Assessing the balance between excitation and inhibition in chronic pain through the aperiodic component of EEG},
journal = {eLife},
year = {2025},
volume = {13},
doi = {10.7554/elife.101727}
}
EUVIMED